Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Immunological Reviews|October 14, 2017
Immune recognition of irradiated cancer cellsErik Wennerberg, Claire Vanpouille-Box, Sophia Bornstein, et al.Vaccine|July 8, 2015
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatmentClaire Vanpouille-Box, Karsten A Pilones, Erik Wennerberg, et al.Trends in Cancer|January 15, 2021
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic PeptidesIlio Vitale, Takahiro Yamazaki, Erik Wennerberg, et al.Frontiers in Immunology|November 29, 2023
Tumour immune escape via P2X7 receptor signallingRicardo M Sainz, Jorge Humberto Rodriguez-Quintero, Maria Constanza Maldifassi, et al.NPJ Breast Cancer|July 24, 2025
The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancerMatthew Fenton, Miki Yoneyama, Erik Wennerberg, et al.European Journal of Immunology|September 22, 2012
Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γDhifaf Sarhan, Padraig D'Arcy, Erik Wennerberg, et al.International Journal of Cancer|March 19, 2013
Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signalingErik Wennerberg, Dhifaf Sarhan, Mattias Carlsten, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2012
HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell linesRiki Okita, Dimitrios Mougiakakos, Takashi Ando, et al.Oncoimmunology|November 22, 2012
Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cellsRolf Kiessling, Riki Okita, Dimitrios Mougiakakos, et al.Oncotarget|February 18, 2020
Exercise reduces immune suppression and breast cancer progression in a preclinical modelErik Wennerberg, Claire Lhuillier, Marissa D Rybstein, et al.Pageof 4